CVRx, Inc. - Common Stock, par value $0.01 per share (CVRX)

Historical Holders from Q2 2021 to Q3 2025

Symbol
CVRX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
25,975,423
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
14,003,450
Holdings value
$113,001,810
% of all portfolios
0%
Number of holders
91
Number of buys
45
Number of sells
-39
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CVRx, Inc. - Common Stock, par value $0.01 per share (CVRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NEW ENTERPRISE ASSOCIATES 10 L P 7.8% $13,635,539 2,026,083 New Enterprise Associates 10, Limited Partnership 18 Feb 2025
Vensana Capital I GP, LLC 7.2% $11,849,740 1,760,734 Kirk Nielsen 31 Dec 2024
Cooperatieve Gilde Healthcare IV U.A. 4.9% $8,287,928 1,231,490 Cooperatieve Gilde Healthcare IV U.A. 04 Feb 2025

Institutional Holders of CVRx, Inc. - Common Stock, par value $0.01 per share (CVRX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 14,003,450 $113,001,810 -$4,160,353 $8.07 91
2025 Q2 14,566,804 $85,403,778 -$19,986,146 $5.88 91
2025 Q1 15,971,769 $195,337,855 +$10,778,190 $12.23 95
2024 Q4 15,154,273 $192,128,165 +$11,666,171 $12.67 91
2024 Q3 14,208,138 $125,172,924 +$5,810,039 $8.81 84
2024 Q2 13,192,379 $158,176,281 -$11,196,197 $11.99 72
2024 Q1 13,441,680 $244,665,057 +$21,036,083 $18.21 87
2023 Q4 12,015,323 $377,446,209 +$6,898,602 $31.44 83
2023 Q3 11,953,961 $181,343,253 +$2,863,854 $15.17 64
2023 Q2 11,594,427 $179,048,989 +$23,946,250 $15.44 66
2023 Q1 10,400,213 $96,928,042 -$20,701,454 $9.32 61
2022 Q4 10,299,118 $188,989,468 +$3,540,115 $18.35 48
2022 Q3 10,529,611 $98,240,851 -$6,931,505 $9.33 37
2022 Q2 10,888,954 $65,444,210 -$7,076,705 $6.01 34
2022 Q1 12,073,187 $72,317,176 -$14,166,594 $5.99 55
2021 Q4 12,884,491 $157,579,777 -$25,347,085 $12.23 53
2021 Q3 11,758,612 $194,426,346 -$15,245,912 $16.54 49
2021 Q2 13,787,189 $386,044,000 +$386,044,000 $28 59